Articles

Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone treated mice

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA;
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA;
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA;
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA;
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA;
Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA;
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA;
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA
Haematologica Early view Jul 16, 2020 https://doi.org/10.3324/haematol.2020.252767